trending Market Intelligence /marketintelligence/en/news-insights/trending/aoshxwffhvorx7dlmuwkaw2 content esgSubNav
In This List

Arcus Biosciences closes $138M IPO

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Arcus Biosciences closes $138M IPO

Arcus Biosciences Inc. closed its IPO of 8 million common shares priced at $15 apiece to raise $138 million in gross proceeds.

The underwriters fully exercised their overallotment option to buy an additional 1.2 million shares.

Citigroup, Goldman Sachs & Co. LLC and Leerink Partners acted as joint book-running managers for the offering.